These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35029348)

  • 1. Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs.
    de Groot AC
    Dermatitis; 2022 Jan-Feb 01; 33(1):16-30. PubMed ID: 35029348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of patch testing for the diagnosis of delayed-type drug hypersensitivity reactions to clindamycin.
    Gilissen L; Huygens S; Goossens A; Breynaert C; Schrijvers R
    Contact Dermatitis; 2020 Sep; 83(3):237-239. PubMed ID: 32333605
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug patch tests in the investigation of cutaneous adverse drug reactions].
    Barbaud A
    Ann Dermatol Venereol; 2009; 136(8-9):635-44. PubMed ID: 19686903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized reactions during skin testing with clindamycin in drug hypersensitivity: a report of 3 cases and review of the literature.
    Papakonstantinou E; Müller S; Röhrbein JH; Wieczorek D; Kapp A; Jakob T; Wedi B
    Contact Dermatitis; 2018 Apr; 78(4):274-280. PubMed ID: 29356000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of patch tests in clindamycin-related drug eruptions.
    Pereira N; Canelas MM; Santiago F; Brites MM; Gonçalo M
    Contact Dermatitis; 2011 Oct; 65(4):202-7. PubMed ID: 21689110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of skin test reactions in patients with non-immediate type drug eruptions.
    Osawa J; Naito S; Aihara M; Kitamura K; Ikezawa Z; Nakajima H
    J Dermatol; 1990 Apr; 17(4):235-9. PubMed ID: 2142173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe cutaneous adverse reactions to drugs.
    Duong TA; Valeyrie-Allanore L; Wolkenstein P; Chosidow O
    Lancet; 2017 Oct; 390(10106):1996-2011. PubMed ID: 28476287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug reaction with eosinophilia and systemic symptoms].
    Tehrany YA; Laffitte E; Grosgurin O; Spoerl D
    Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of skin testing in the investigation of cutaneous adverse drug reactions.
    Barbaud A; Reichert-Penetrat S; Tréchot P; Jacquin-Petit MA; Ehlinger A; Noirez V; Faure GC; Schmutz JL; Béné MC
    Br J Dermatol; 1998 Jul; 139(1):49-58. PubMed ID: 9764148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patch testing for drugs.
    Aquino MR; Sher J; Fonacier L
    Dermatitis; 2013; 24(5):205-14. PubMed ID: 24030368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the hidden culprit: A case report of recurrent SDRIFE caused by a systemic corticosteroid masquerading as antibiotic allergies.
    Beaulieu V; Matei I; Bel Hareth K; Ingen-Housz-Oro S; Assier H
    Contact Dermatitis; 2024 Jul; 91(1):88-90. PubMed ID: 38572964
    [No Abstract]   [Full Text] [Related]  

  • 16. Patch testing in drug allergy.
    Friedmann PS; Ardern-Jones M
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):291-6. PubMed ID: 20485160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patch testing for evaluating drug reactions due to systemic antibiotics.
    Cham PM; Warshaw EM
    Dermatitis; 2007 Jun; 18(2):63-77. PubMed ID: 17498411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is drug allergy less prevalent than previously assumed? A 5-year analysis.
    Heinzerling LM; Tomsitz D; Anliker MD
    Br J Dermatol; 2012 Jan; 166(1):107-14. PubMed ID: 21916887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatic failure in trimethoprim-induced drug rash with eosinophilia and systemic symptoms (DRESS).
    Connolly A; Walsh S; Philippidou M; Salisbury J; Creamer D
    Br J Dermatol; 2023 Jul; 189(1):140-141. PubMed ID: 36946217
    [No Abstract]   [Full Text] [Related]  

  • 20. Patch testing in cutaneous reactions caused by carbamazepine.
    Alanko K
    Contact Dermatitis; 1993 Nov; 29(5):254-7. PubMed ID: 8112065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.